Neuropsychopharmacology Reviews, 2014 · DOI: 10.1038/npp.2013.237 · Published: January 1, 2014
The central nervous system (CNS) has limited ability to repair itself after injury or disease. Current treatments often fail to fully restore function. Researchers are exploring new methods using biomaterials to help the CNS regenerate. Cell therapy, which involves transplanting stem cells, has shown promise but faces challenges like poor cell survival and integration. Similarly, delivering drugs to the CNS is difficult because of the blood-brain barrier (BBB). Biomaterials, especially hydrogels, are being developed as delivery vehicles for cells and drugs. These materials can protect cells, improve their integration into the CNS, and provide localized and sustained release of therapeutic molecules.
Biomaterials can improve the efficacy of cell transplantation by promoting cell survival and integration into the host tissue.
Biomaterials can provide targeted and prolonged release of therapeutic molecules, reducing the need for multiple injections and minimizing systemic side effects.
Combination strategies involving cells, bioactive molecules, and biomaterials can lead to enhanced tissue regeneration and functional recovery in CNS diseases and injuries.